RAPTA-C

CAS No. 372948-28-2

RAPTA-C( —— )

Catalog No. M34689 CAS No. 372948-28-2

RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 In Stock
10MG 236 In Stock
25MG 404 In Stock
50MG 574 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RAPTA-C
  • Note
    Research use only, not for human use.
  • Brief Description
    RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
  • Description
    RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    372948-28-2
  • Formula Weight
    463.35
  • Molecular Formula
    C16H26Cl2N3PRu
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [Cl-][Ru+2]12345([Cl-])([CH]=6[CH]5=C4(C(C)C)[CH]3=[CH]2C61C)[P]78CN9CN(CN(C9)C7)C8
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • p53 Activator 7

    p53 Activator 7 is a highly potent and cell-permeable activator of the p53 mutation Y220C (MDM-2/p53), which induces apoptosis.

  • Lupiwighteone

    Lupiwighteone has anti-angiogenesis potential, it also has anticancer and cancer preventive effects on SH-SY5Y cells.

  • Necrox-5 methanesulf...

    NecroX-5 is a novel necroptosis inhibitor that reduces mitochondrial oxidative stress, prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter.